CIK 0000728387
- Non-accelerated filer
- Smaller reporting company
Perspective Therapeutics, Inc.
Sign in to watch- Ticker
- CATX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 411458152
- Phone
- +1 206-676-0900
- Business address
- 2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
- Former names
- IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
- 4 Open-market buy Controller/Prin Fin&Acct Offic bought 19,230 shares at $0.52 ($10,000)
- 4 Open-market buy EVP of Sales & Marketing bought 28,844 shares at $0.52 ($14,999)
- 4 Open-market buy Chief Financial Officer bought 67,306 shares at $0.52 ($34,999)
- 4 Open-market buy Chief R&D Officer bought 7,692 shares at $0.52 ($4,000)
- 4 Open-market buy Director bought 19,230 shares at $0.52 ($10,000)
- 4 Open-market buy Director bought 19,230 shares at $0.52 ($10,000)
- 4 Open-market buy Director bought 20,000 shares at $0.52 ($10,400)
- 4 Open-market buy CEO bought 48,076 shares at $0.52 ($25,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion CEO acquired 262,500 shares (option exercise)
- 4 Open-market buy VP of Sales & Marketing bought 50,000 shares at $0.39 ($19,495)
Page 7 of 17 · 339 filings